4//SEC Filing
Avniel Amir 4
Accession 0001493152-22-018553
CIK 0001641631other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:45 PM ET
Size
7.8 KB
Accession
0001493152-22-018553
Insider Transaction Report
Form 4
Beyond Air, Inc.XAIR
Avniel Amir
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2022-06-30$6.50/sh−65,500$425,979→ 408,027 total - Sale
Common Stock
2022-06-30$6.57/sh−2,600$17,094→ 13,733 total(indirect: Held by Dandelion Investments Ltd.)
Footnotes (3)
- [F1]The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017.
- [F2]The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.47 to $6.59, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.585, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
Documents
Issuer
Beyond Air, Inc.
CIK 0001641631
Entity typeother
Related Parties
1- filerCIK 0001426873
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:45 PM ET
- Size
- 7.8 KB